Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for BDRFY and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for BDRFY and 80,000+ other tickers.
See exactly how BDRFY's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for BDRFY and 80,000+ other tickers.
Beiersdorf Aktiengesellschaft operates as a global producer and distributor of consumer goods, with operations spanning Europe, the Americas, Africa, Asia, and Australia. The company structures its business into two primary divisions: Consumer Business and Tesa Business. Its Consumer Business segment specializes in a wide array of skin and body care products. Conversely, the Tesa Business division focuses on adhesive solutions, supplying adhesive tapes, self-adhesive items, and specialized system solutions. These offerings cater to a diverse clientele, including large industries, smaller…
Beiersdorf Aktiengesellschaft (BDRFY) Q2 2026 Earnings Call Transcript
Beiersdorf Aktiengesellschaft ETR: BEI reported a weaker first half of 2026 as continued pressure at NIVEA outweighed growth in its Derma and Healthcare businesses. The company lowered its full-year outlook for its consumer segment and group sales, while outlining an 18-month plan intended to restore NIVEA to sustainable growth.
Nivea-maker Beiersdorf said conflict in the Middle East is disrupting both sales and deliveries in key Gulf markets, highlighting how geopolitical tensions continue to affect consumer-goods companies operating in the region.
Beiersdorf trimmed its guidance on Monday and now expects an organic sales decline in the low-single digit percentage range this year.
Beiersdorf is now fairly valued after a significant decline, with an intrinsic value estimated at €68.85 per share. Recent results show organic growth of 2.4% in 2025, but Q1 2026 saw a 4.6% organic sales decline, with Nivea under particular pressure. Management maintains flat-to-slightly-positive 2026 guidance, citing Derma segment strength and early signs of Nivea recovery, despite analyst skepticism.